Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Dead Zone
    • Deadly Denials
    • Diagnosis: Debt
    • Guns, Race, and Profit
    • Overpayment Outrage
    • Payback: Tracking Opioid Cash
    • Priced Out
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Date
Custom Date Range
Topic
Content Type

Showing 7581-7600 of 131,612 results

Thousands Of Frontline Worker Covid Deaths Due To Govt. Failures: Report

January 31, 2024 Morning Briefing

A new study published in the BMJ calls attention to failures in the U.S. regulatory system that contributed to the deaths of thousands of frontline workers during the pandemic. Separate research shows up to 75% of adults have hidden an infectious illness in order to work, travel, or socialize.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Experimental Non-Opioid Pain Drug Achieves Success In Studies

January 31, 2024 Morning Briefing

Vertex Pharmaceuticals’ new drug works by blocking pain signals before they get to the brain and is expected to avoid some issues that opioid pain drugs cause via addiction. The new drug is sparking debate on how widely it would be used if it wins regulatory approval.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Morning Briefing for Wednesday, January 31, 2024

January 31, 2024 Morning Briefing

STD rates, measles cases, covid, Medicaid drug costs, violence against health workers, a non-opioid pain drug, and more are in the news.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Syphilis Cases Rise In US While Other STDs Fall Or Stay Flat

January 31, 2024 Morning Briefing

According to CDC data, syphilis incidences rose 9% in 2022, and have increased 80% since 2018. Gonorrhea cases dropped for the first time in a decade though.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

First Edition: Jan. 31, 2024

January 31, 2024 Morning Briefing

Today’s early morning highlights from the major news organizations.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
A photo of two EpiPen packs.

The FTC Is Attacking Drugmakers’ ‘Patent Thickets’

By Elisabeth Rosenthal January 31, 2024 KFF Health News Original

It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
A photo of the exterior of Montana's Department of Health and Human Services.

Montana Vows Changes to Avoid Delayed Contracts. Some Health Providers Still Await Back Pay.

By Katheryn Houghton January 31, 2024 KFF Health News Original

The head of Montana’s health department said the agency is catching up on a months-long backlog of contracts with organizations that connect people to medical care that left organizations without pay, halted some services, and triggered job cuts.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
A photo of a nurse helping a woman with her ketamine treatment.

Ketamine Therapy for Mental Health a ‘Wild West’ for Doctors and Patients

By Dawn Megli January 31, 2024 KFF Health News Original

Ketamine, approved by the FDA as an anesthetic in 1970, is emerging as a major alternative mental health treatment, and there are now more than 500 ketamine clinics around the country. But with little regulation and widely varying treatment protocols, it’s a medical “wild West.”

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Empty medical office in a hospital.

¿Dónde están los proveedores de atención primaria del país? La respuesta no es fácil

By Rae Ellen Bichell January 30, 2024 KFF Health News Original

Expertos en el tema sienten una frustración persistente: es difícil saber si alguna política está funcionando porque los datos que recopila el gobierno federal sobre las áreas de escasez de atención primaria no han sido fidedignos durante mucho tiempo.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

A Legal Battle Over Herring Fishing Has Big Implications for Health Care

By Julie Rovner January 30, 2024 KFF Health News Original

What do herring fishing and health policy have in common? Quite a bit, it turns out, owing to a case now before the Supreme Court. If the justices rule as expected, based on this month’s oral arguments, they could dramatically change the way federal health agencies operate. “The upheaval caused … would be immense,” argues […]

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Viewpoints: Rise In Colon Cancer In Younger Generation Baffles Doctors; Are MAID Rules Too Lenient?

January 30, 2024 Morning Briefing

Editorial writers tackle colon cancer, doctor-assisted euthanasia, child tax credits, and more.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Texas Supreme Court To Hear Challenge To Youth Gender Care Ban

January 30, 2024 Morning Briefing

In other news, Ohio may be set to follow after Alabama used nitrogen gas in an execution for the first time. Also: HCA North Florida Hospital has extended its surgery shutdown after an instrument sterilization problem; Colorado’s aid-in-dying rules may change; and more.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Closed Illinois Hospital Will Be Reopened By OSF Healthcare

January 30, 2024 Morning Briefing

The hospital in Peru, Illinois had been recently shuttered and will now open April 7, offering emergency services and a limited inpatient facility. Also in the news: Steward Health Care’s financial issues; ProMedica’s Paramount Health acquisition by Medical Mutual; and more.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Analysts Expect Medicare To Press Industry For Steep Drug Price Cuts

January 30, 2024 Morning Briefing

The Medicare program’s first ever price negotiations are set to begin, with experts expecting pressure for deep cuts on 10 high-cost medicines. Meanwhile, in Europe regulators are promoting their successes in regulating big pharma.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

First Amendment Case On Covid Misinfo Control Heads To Supreme Court

January 30, 2024 Morning Briefing

The lawsuit, which will be heard in March, centers on questions around the federal government’s role in requesting that tech giants suppress covid misinformation during the pandemic. Also, HHS Secretary Xavier Becerra defended federal covid isolation guidelines that California has deviated from.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Using Alcohol, Drugs As A Teen Linked To Psychiatric Distress

January 30, 2024 Morning Briefing

New research published Monday in JAMA Pediatrics found that teens who use cannabis, alcohol, and nicotine are more likely to have underlying mental symptoms. Separate research shows that college students suffering discrimination are more likely to report mental health challenges.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Possible Shot Contamination Linked To Five Early Alzheimer’s Cases

January 30, 2024 Morning Briefing

Five people in the U.K. may have developed Alzheimer’s because of contaminated human growth hormone injections they received as children, a new study suggests. Meanwhile, reports say new Alzheimer’s drugs are bringing hope to some patients, but not equally.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Morning Briefing for Tuesday, January 30, 2024

January 30, 2024 Morning Briefing

Primary care shortages, mifepristone, drug prices, brain implant trial, hospital closings, mental health, misinfo, and more are in the news.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Mifepristone Supreme Court Case Will Be Heard On March 26

January 30, 2024 Morning Briefing

The Supreme Court has scheduled arguments for March 26 in a closely watched case over access to mifepristone, one of two drugs used most commonly in the U.S. for a medication abortion. Issues of FDA authority are also at stake in the lawsuit.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Neuralink’s First Human Brain Implant Trial Gets Underway

January 30, 2024 Morning Briefing

The patient received the first human Neuralink system Sunday and is said to be recovering well. It received FDA permission to begin human trials back in May, and the company began recruiting patients in the fall.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Previous
  • 378
  • 379
  • 380
  • 381
  • 382
  • Next

More From KFF Health News

A photo of Mehmet Oz speaking at a podium at the White House. American flags are seen behind him.

Oz Says California’s Not Fighting Health Care Fraud, but Data Shows It’s Part of a Larger Battle

Lawmakers Seek To Protect Crisis Pregnancy Centers as Abortion Clinic Numbers Shrink

Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds.

The "What the Health? From KFF Health News Logo" beside two black and white photos of Drew Altman and Julie Rovner.

Watch: Affordability Plagues Health Care in Its Shift From Nonprofit to Profit Machine

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue